Frontiers in Clinical Drug Research - Anti-Cancer Agents

Volume 5

by

Atta-ur-Rahman

DOI: 10.2174/97898114051501190501
eISBN: 978-981-14-0515-0, 2019
ISBN: 978-981-14-0514-3
ISSN: 2451-8905 (Print)
ISSN: 2215-0803 (Online)



Recommend this eBook to your Library or Friend



Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate student...[view complete introduction]
US $
Buy Personal eBook
89
Order Library eBook
356
Order Printed Copy
*107
Order PDF + Printed Copy (Special Offer)
*151

*(Excluding Mailing and Handling)

🔒Secure Checkout Personal information is secured with SSL technology

Table of Contents

Preface

- Pp. i
Atta-ur-Rahman
Download Free

List of Contributors

- Pp. ii
Atta-ur-Rahman
Download Free

Second-Generation Protein Kinase Inhibitor – A Focus on Quizartinib, A Promising Targeted Therapy for High-Risk FLT3+ Patients with Acute Myeloid Leukemia

- Pp. 1-21 (21)
Xavier Thomas and Etienne Paubelle
View Abstract Purchase Chapter

Physical Exercise for Cancer Patients Treated with Chemotherapy

- Pp. 22-49 (28)
Shinichiro Morishita, Atsuhiro Tsubaki and Jack B. Fu
View Abstract Purchase Chapter

Cancer Immune Evasion in Gastrointestinal Cancer: Can this be Overcome by Combination of Histone Deacetylase and Immune Checkpoint Inhibitors?

- Pp. 50-84 (35)
Yuequan Shi, Onyinyechi Duru, Zifang Zou and David Kerr
View Abstract Purchase Chapter

Long Non-Coding RNAs in Cancer Progression: Implication for Anti-Cancer Therapy

- Pp. 85-112 (28)
Chang Gong, Zihao Liu, Andrew J. Sanders and Wen G. Jiang
View Abstract Purchase Chapter

Ros-Mediated Induction of Apoptosis in Breast Cancer Cells

- Pp. 113-121 (9)
Işıl Yıldırım
View Abstract Purchase Chapter

Generations of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Battle against Drug Resistant Lung Cancer

- Pp. 122-165 (44)
Kenneth K.W. To and Wing-Sum Tong
View Abstract Purchase Chapter

Subject Index

- Pp. 166-174 (9)
Atta-ur-Rahman
Download Free

Preface

Frontiers in Clinical Drug Research - Anti-Cancer Agents presents recent developments in various therapeutic approaches against different types of cancer. The book is a valuable resource for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. The chapters are written by authorities in the field. The contents of this volume represent exciting recent researches on Acute Myeloid Leukemia, Chemotherapy, Gastrointestinal Cancer, Anti-cancer Therapy, Breast Cancer Cells, and Lung Cancer. I hope that the readers will find these reviews valuable and thought provoking so that they may trigger further research in the quest for the new and novel therapies against cancers.

I am grateful for the timely efforts made by the editorial personnel, especially Mr. Mahmood Alam (Director Publications), and Mr. Shehzad Naqvi (Editorial Manager Publications) at Bentham Science Publishers.

Atta-ur-Rahman, FRS
Honorary Life Fellow
Kings College
University of Cambridge
UK

List of Contributors

Editor(s):
Atta-ur-Rahman
Honorary Life Fellow
University of Cambridge
Cambridge
UK




Contributor(s):
Atsuhiro Tsubaki
Institute for Human Movement and Medical Sciences
Niigata University of Health and Welfare
Niigata
Japan


Andrew J. Sanders
Cardiff China Medical Research Collaborative, Cardiff University School of Medicine, Cardiff University, Heath Park
Cardiff
UK


Chang Gong
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetic and Gene Regulation, Breast Tumor Center, Sun Yat-sen Memorial Hospital
Sun Yat-sen University
Varna
China


David Kerr
Radcliffe Department of Medicine
University of Oxford
UK


Etienne Paubelle
Hematology Department
University of Arizonaospices Civils de Lyon, Lyon-Sud Hospital
Pierre Bénite
France


Işıl Yıldırım
Beykent University, Vocational School
The University of Hong Kong
Istanbul
Turkey


Jack B. Fu
Department of Palliative, Rehabilitation Integrative Medicine
University of Texas MD Anderson Cancer Center
Houston, TX
USA


Kenneth K.W. To
School of Pharmacy, Faculty of Medicine
The Chinese University of Hong Kong
Hong Kong SAR
China


Onyinyechi Duru
Department of Oncology
Nottingham University Hospital, City Campus
Nottingham
UK


Shinichiro Morishita
Institute for Human Movement and Medical Sciences
Niigata University of Health and Welfare
Niigata
Japan


Wen G. Jiang
Cardiff China Medical Research Collaborative, Cardiff University School of Medicine, Cardiff University, Heath Park
Cardiff
UK


Wing-Sum Tong
School of Pharmacy, Faculty of Medicine
The Chinese University of Hong Kong
Hong Kong SAR
China


Xavier Thomas
Hematology Department
University of Arizonaospices Civils de Lyon, Lyon-Sud Hospital
Pierre Bénite
France


Yuequan Shi
China Medical University
Liaoning
China


Zifang Zou
China Medical University
Liaoning
China


Zihao Liu
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetic and Gene Regulation, Breast Tumor Center, Sun Yat-sen Memorial Hospital
Sun Yat-sen University
Varna
China




Advertisement



Webmaster Contact: info@benthamscience.net Copyright © 2019 Bentham Science